Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001354488-11-003139
Filing Date
2011-08-29
Accepted
2011-08-29 17:16:44
Documents
2
Period of Report
2011-04-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 oxbt_10ka.htm 10-K/A 801997
2 CERTIFICATION oxbt_ex311.htm EX-31.1 11283
  Complete submission text file 0001354488-11-003139.txt   814636
Mailing Address 2530 MERIDIAN PARKWAY SUITE 3084 DURHAM NC 27713
Business Address 2530 MERIDIAN PARKWAY SUITE 3084 DURHAM NC 27713 919-806-4414
OXYGEN BIOTHERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1109
Type: 10-K/A | Act: 34 | File No.: 001-34600 | Film No.: 111063639
SIC: 8731 Services-Commercial Physical & Biological Research